As an integral member of the Pfizer Clinical Pharmacology team, you will support late stage programs in oncology. ROLE RESPONSIBILITIES
- Act as Clinical Pharmacology representative providing clinical pharmacology expertise to a multidisciplinary study team for one or more late-stage Internal Medicine programs.
- Participate in implementing model-informed drug development using quantitative approaches to address questions arising during drug development (including dose selection, clinical trial design, special population dosing, benefit/risk assessment).
- Work closely with clinicians, statisticians, and clinical operations colleagues to design, conduct and report results of Clinical Pharmacology trials.
- Accountable for non-compartmental analysis of PK data and accountable for ensuring appropriate PK-PD analysis including population PK, PK-PD modeling and simulation, meta-analysis, etc.
- Responsible for providing the clinical pharmacology components of protocols, clinical development plans and regulatory documents.
- Influences environment outside of Pfizer through methods such as publications and presentations.
- PhD or PharmD with 8+ years of drug development experience
- Strong quantitative pharmacology skills including hands-on experience in the implementation of common software tools (e.g., NONMEM, R) for PK and PK/PD analyses.
- Experience interpreting PK and PK/PD data and integrating this knowledge into the clinical trial and overall clinical program
- Strong written and verbal communication skills
Must demonstrate a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
\nPfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.